(0.27%) 5 105.25 points
(0.60%) 38 614 points
(0.61%) 17 758 points
(0.35%) $79.23
(-0.84%) $2.02
(0.32%) $2 317.00
(0.51%) $26.97
(0.48%) $967.20
(-0.09%) $0.931
(-0.17%) $10.97
(-0.17%) $0.797
(0.87%) $91.92
-0.50% € 2.00
Live Chart Being Loaded With Signals
Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections...
Stats | |
---|---|
Dzisiejszy wolumen | 3 154.00 |
Średni wolumen | 10 506.00 |
Kapitalizacja rynkowa | 15.83M |
EPS | €0 ( 2023-03-07 ) |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -2.67 |
ATR14 | €0.103 (5.23%) |
Wolumen Korelacja
Pherecydes Pharma Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pherecydes Pharma Korelacja - Waluta/Towar
Pherecydes Pharma Finanse
Annual | 2022 |
Przychody: | €3.16M |
Zysk brutto: | €-93 178.00 (-2.95 %) |
EPS: | €-0.750 |
FY | 2022 |
Przychody: | €3.16M |
Zysk brutto: | €-93 178.00 (-2.95 %) |
EPS: | €-0.750 |
FY | 2021 |
Przychody: | €2.14M |
Zysk brutto: | €659 036 (30.76 %) |
EPS: | €-0.564 |
FY | 2019 |
Przychody: | €2.26M |
Zysk brutto: | €0.00 (0.00 %) |
EPS: | €-0.216 |
Financial Reports:
No articles found.
Pherecydes Pharma
Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections. The company was founded in 2006 and is based in Romainville, France.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej